Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CHR NYSE:FC CVE:MMY NASDAQ:NEO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHRCheer$1.72-4.7%$2.57$1.25▼$313.50$2.81M0.8662,088 shs29,300 shsFCFranklin Covey$22.51+2.8%$17.31$11.16▼$24.70$246.75M0.78119,000 shs80,191 shsMMYMonument MiningC$0.82-1.2%C$0.98C$0.38▼C$1.55C$283.80M1.392837720,386 shs394,842 shsNEONeoGenomics$8.86-1.6%$8.44$4.72▼$13.74$1.17B1.812.74 million shs1.52 million shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHRCheer0.00%+10.18%-22.85%-49.73%-99.15%FCFranklin Covey0.00%+0.84%-9.48%+8.63%+1.14%MMYMonument Mining0.00%-1.18%-14.29%-30.00%+90.91%NEONeoGenomics0.00%+9.64%+18.00%-24.48%+22.60%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHRCheer$1.72-4.7%$2.57$1.25▼$313.50$2.81M0.8662,088 shs29,300 shsFCFranklin Covey$22.51+2.8%$17.31$11.16▼$24.70$246.75M0.78119,000 shs80,191 shsMMYMonument MiningC$0.82-1.2%C$0.98C$0.38▼C$1.55C$283.80M1.392837720,386 shs394,842 shsNEONeoGenomics$8.86-1.6%$8.44$4.72▼$13.74$1.17B1.812.74 million shs1.52 million shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHRCheer0.00%+10.18%-22.85%-49.73%-99.15%FCFranklin Covey0.00%+0.84%-9.48%+8.63%+1.14%MMYMonument Mining0.00%-1.18%-14.29%-30.00%+90.91%NEONeoGenomics0.00%+9.64%+18.00%-24.48%+22.60%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHRCheer 1.00SellN/AN/AFCFranklin Covey 2.33Hold$26.0015.53% UpsideMMYMonument Mining 3.00BuyC$2.10156.10% UpsideNEONeoGenomics 2.38Hold$13.8656.40% UpsideCurrent Analyst Ratings BreakdownLatest MMY, NEO, CHR, and FC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/29/2026NEONeoGenomics BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$11.004/29/2026NEONeoGenomics TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$13.00 ➝ $14.004/29/2026NEONeoGenomics Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$12.00 ➝ $25.004/20/2026CHRCheer Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)4/10/2026FCFranklin Covey Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)4/2/2026FCFranklin Covey Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$25.003/27/2026NEONeoGenomics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/25/2026FCFranklin Covey Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$25.003/17/2026MMYMonument Mining Fundamental ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuyC$2.103/16/2026NEONeoGenomics William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingMarket Perform3/16/2026NEONeoGenomics TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHRCheer$148.84M0.02$19.06 per share0.09$236.74 per share0.01FCFranklin Covey$267.07M0.95$1.65 per share13.62$5.29 per share4.25MMYMonument MiningC$141.10M2.01C$0.57 per share1.43C$0.53 per share1.54NEONeoGenomics$727.33M1.59$0.33 per share26.86$6.36 per share1.39Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHRCheer$25.62MN/AN/AN/AN/AN/AN/AN/AN/AFCFranklin Covey$3.07M-$0.21N/A24.731.37-0.88%12.79%3.23%7/1/2026 (Estimated)MMYMonument MiningC$6.70MC$0.165.13N/AN/A39.99%35.03%6.37%N/ANEONeoGenomics-$108.03M-$0.77N/A295.33N/A-13.30%-2.80%-1.72%N/ALatest MMY, NEO, CHR, and FC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/28/2026Q1 2026NEONeoGenomics$0.0058$0.01+$0.0042-$0.13$184.54 million$186.67 million4/1/2026Q2 2026FCFranklin Covey$0.03-$0.03-$0.06-$0.17$58.71 million$59.65 million3/20/2026Q4 2025CHRCheer$345.00-$14.1450-$359.1450-$14.1450$73.00 million$38.92 million2/17/2026Q4 2025NEONeoGenomics$0.04$0.06+$0.02-$0.08$188.25 million$190.17 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCHRCheerN/AN/AN/AN/AN/AFCFranklin CoveyN/AN/AN/AN/AN/AMMYMonument MiningN/A24.39%N/AN/AN/ANEONeoGenomicsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHRCheerN/A11.5311.53FCFranklin CoveyN/A0.630.59MMYMonument Mining0.054.572.36NEONeoGenomics0.414.424.06Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHRCheer18.54%FCFranklin Covey69.88%MMYMonument Mining2.05%NEONeoGenomics98.50%Insider OwnershipCompanyInsider OwnershipCHRCheer41.70%FCFranklin Covey15.20%MMYMonument Mining18.37%NEONeoGenomics1.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHRCheer1271.56 million911,000N/AFCFranklin Covey1,12011.27 million9.56 millionOptionableMMYMonument Mining39,500346.10 millionN/ANot OptionableNEONeoGenomics2,500130.21 million128.78 millionOptionableMMY, NEO, CHR, and FC HeadlinesRecent News About These CompaniesA Look At NeoGenomics (NEO) Valuation After Q1 2026 Results And Epic Aura Oncology IntegrationMay 1, 2026 | finance.yahoo.comNEO Q1 deep dive: High-value test expansion and commercial execution drive oncology growthApril 30, 2026 | msn.comLeerink Partners upgrades NeoGenomics (NEO)April 30, 2026 | msn.comNeoGenomics Inc (NEO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...April 30, 2026 | finance.yahoo.comNeoGenomics’s (NASDAQ:NEO) Q1 CY2026: Beats On RevenueApril 30, 2026 | finance.yahoo.comNeoGenomics signals $797M-$803M 2026 revenue outlook following PanTracer Liquid MolDX approvalApril 30, 2026 | seekingalpha.comTD Cowen Issues Positive Forecast for NeoGenomics (NASDAQ:NEO) Stock PriceApril 29, 2026 | marketbeat.comNeoGenomics (NASDAQ:NEO) Shares Gap Up Following Analyst UpgradeApril 29, 2026 | marketbeat.comNeoGenomics (NASDAQ:NEO) Upgraded by Leerink Partners to Outperform RatingApril 29, 2026 | marketbeat.comNeoGenomics, Inc. (NEO) Q1 2026 Earnings Call TranscriptApril 29, 2026 | seekingalpha.comNeoGenomics (NASDAQ:NEO) Announces Quarterly Earnings Results, Hits EstimatesApril 28, 2026 | marketbeat.comNeoGenomics Q1 Earnings Call HighlightsApril 28, 2026 | marketbeat.comNeoGenomics, Inc. 2026 Q1 - Results - Earnings Call PresentationApril 28, 2026 | seekingalpha.comNeoGenomics Reports First Quarter 2026 ResultsApril 28, 2026 | businesswire.comAll eyes on NeoGenomics earnings amid volume growth questionsApril 28, 2026 | investing.comNeoGenomics earnings: What to look for from NEOApril 27, 2026 | msn.comNeoGenomics (NEO) Q4 2024 Earnings TranscriptApril 23, 2026 | finance.yahoo.comNeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura IntegrationApril 23, 2026 | businesswire.comNeoGenomics (NEO) Projected to Post Earnings on TuesdayApril 21, 2026 | marketbeat.comNeoGenomics (NASDAQ:NEO) Stock Price Down 5.3% - Here's What HappenedApril 16, 2026 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Hold" by BrokeragesApril 14, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesCould Easing Iran Tensions Trigger an Amazon Pre-Earnings Rally?By Sam Quirke | April 6, 2026Allbirds Exits Shoes, Pivots to AI With NewBird RebrandBy Leo Miller | April 21, 2026Apple’s Hinge Cringe: Foldable Flop or Strategic Stop? By Jeffrey Neal Johnson | April 9, 2026Aeluma’s Market Is Laser-Focused on Fresh Highs—Here’s WhyBy Thomas Hughes | April 20, 20263 eVTOL Stocks, 3 Flight Plans: Which One Will Stick the Landing?By Jeffrey Neal Johnson | April 22, 2026MMY, NEO, CHR, and FC Company DescriptionsCheer NASDAQ:CHR$1.72 -0.08 (-4.71%) Closing price 03:56 PM EasternExtended Trading$1.70 -0.02 (-0.89%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cheer Holding, Inc., through its subsidiaries, provides advertisement and content production services in the People's Republic of China. It operates through Cheers APP Internet Business and Traditional Media Businesses segments. The company also engages in mobile and online advertising, and media and entertainment businesses. In addition, it operates CHEERS app, an integrated e-commerce service with professionally produced content; CHEERS Video app, a media platform that engages users with content; and CHEERS e-Mall, an e-Mall app that offers products to the users through third party merchants through live streaming, online short videos, and online games. The company also provides CHEERS Telepathy, an artificial intelligence content creation platform; CHEERS Open Data, a platform that provides industry solutions; CheerCar, an interactive entertainment app; CheerReal, a digital collection NFT app; and production, such as short videos, online variety shows, online drama, live stream, and Cheers series. In addition, it is developing CheerChat App, a social app; and CHEERS Metaverse, a platform to provide immersive digital experiences. The company was formerly known as Glory Star New Media Group Holdings Limited and changed its name to Cheer Holding, Inc. in November 2023. Cheer Holding, Inc. was founded in 2016 and is headquartered in Beijing, the People's Republic of China.Franklin Covey NYSE:FC$22.50 +0.62 (+2.81%) Closing price 03:59 PM EasternExtended Trading$22.48 -0.02 (-0.09%) As of 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Franklin Covey Co. provides training and consulting services in the areas of execution, sales performance, productivity, customer loyalty, and educational improvement for organizations and individuals worldwide. The company operates through Direct Offices, International Licensees, and Education Practice segments. It also provides a suite of individual-effectiveness and leadership-development training and products. In addition, the company operates Strive platform, a learning deployment platform; Impact platform that helps automate implementation of learning initiatives; All Access Pass, a subscription platform that enables improved deployment of content, services, technology, and metrics to deliver behavioral impact at scale; and Leader in Me, which provides access to digital versions of student leadership guides, leadership lessons, illustrated leadership stories, and other resources. Franklin Covey Co. was incorporated in 1983 and is headquartered in Salt Lake City, Utah.Monument Mining CVE:MMYC$0.82 -0.01 (-1.20%) As of 03:59 PM EasternMonument Mining Limited operates as a gold producer, engages in the acquisition, exploration, and development of gold, precious metals, and other base metal properties in Canada, Australia, and Malaysia. The company holds 100% interest in the Selinsing gold mine, including the Selinsing, Buffalo Reef, Felda Land, and Famehub projects that are located in Pahang State within the Central Gold Belt of Western Malaysia; and the Murchison gold project portfolio comprising the Burnakura, Tuckanarra, and Gabanintha projects, which are located in the Murchison region of Western Australia. The company is headquartered in Vancouver, Canada.NeoGenomics NASDAQ:NEO$8.86 -0.14 (-1.56%) Closing price 04:00 PM EasternExtended Trading$9.01 +0.15 (+1.64%) As of 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom The Great Chip Divide: AI Chip War Pivots from Hype to Execution Atomic Dividends: Big Tech's New Energy Bet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
